Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial

BACKGROUND: Human papillomavirus (HPV) is one of the most significant risk factors for cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical cancer. The present study aimed to investigate the impact of prophylactic quadrivalent HPV vaccine in the treatment of wo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Public Health
Main Authors: Karimi-Zarchi, Mojgan, Allahqoli, Leila, Nehmati, Ameneh, Kashi, Abolfazl Mehdizadeh, Taghipour-Zahir, Shokouh, Alkatout, Ibrahim
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7045378/
https://ncbi.nlm.nih.gov/pubmed/32106837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12889-020-8371-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados